The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.
Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders
Open accessAbstract
This paper proposes a heuristic framework for an Addictions Neuroclinical Assessment (ANA) that incorporates key functional domains derived from the neurocircuitry of addiction. We review how addictive disorders (AD) are presently diagnosed, and the need for new neuroclinical measures to differentiate patients who meet clinical criteria for addiction to the same agent while differing in etiology, prognosis and treatment response. The need for a better understanding of the mechanisms provoking and maintaining addiction, as evidenced by the limitations of current treatments and within-diagnosis clinical heterogeneity, is articulated. In addition, recent changes in the nosology of AD, challenges to current classification systems, and prior attempts to subtype individuals with AD are described. Complementary initiatives, including the Research Domain Criteria (RDoC) project, which have established frameworks for the neuroscience of psychiatric disorders, are discussed. Three domains, executive function, incentive salience, and negative emotionality, tied to different phases in the cycle of addiction, form the core functional elements of AD. Measurement of these domains in epidemiologic, genetic, clinical, and treatment studies will provide the underpinnings for an understanding of cross-population and temporal variation in addictions, shared mechanisms in addictive disorders, impact of changing environmental influences, and gene identification. Finally, we show that it is practical to implement such a deep neuroclinical assessment using a combination of neuroimaging and performance measures. Neuroclinical assessment is key to reconceptualizing the nosology of AD on the basis of process and etiology, an advance that can lead to improved prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Advances in diagnosis that reflect such an endophenotype or research domain criterion approach will synergistically combine with advances in neurobiology to promote novel pharmacotherapeutic, brain stimulation (ie, transcranial magnetic stimulation and direct electrical stimulation), and behavioural treatments.186”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [186]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the Addictions Neuroclinical Assessment, five subdomains of negative emotional states that can be operationally measured in human laboratory settings and paralleled by animal models were outlined (Kwako et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kwako et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a nosology perspective, the Addictions Neuroclinical Assessment framework allows the identification of individuals with phenotypes that signal dysregulation in this domain (Kwako et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kwako et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“a neurofunctional domain that is postulated to be relevant to early onset of risky alcohol use and the development and maintenance of AUDs (15).”
From Impact of Childhood Trauma on Executive Function in Adolescence—Mediating Functional Brain Networks and Prediction of High-Risk Drinking (2020) · cites this paper as [15]
In the citing paper
“third, it integrates measures for an understanding of the overall functioning of a domain”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“The ANA domains, which encompass only a small fraction of the biomarker space for addiction, are incentive salience (see Glossary), negative emotionality, and executive function [2].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“The ANA domains, which encompass only a small fraction of the biomarker space for addiction, are incentive salience (see Glossary), negative emotionality, and executive function [2].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“fourth, it is a research approach for assessment of addiction, not capable, or intended to diagnose DSM-based alcohol/substance use disorders.”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“first, it targets measures towards domains that are mechanistically important”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067
Development and validation of a brief screening version of the Childhood Trauma Questionnaire
Bernstein, D. P., Stein, J. A., Newcomb, M. D., Walker, E., Pogge, D., Ahluvalia, T., Stokes, J., Handelsman, L., Medrano, M., Desmond, D., et al. (2003) · Child Abuse & Neglect · doi:10.1016/s0145-2134(02)00541-0 · Cited by 6,419
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationBagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90005-1 · Cited by 5,293
The Fifth Edition of the Addiction Severity Index.
Mclellan, A., Kushner, H., Metzger, D., Peters, R., Smith, I. E., Grissom, G. R., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,280
Flagged first, then by citations
4 of the 151 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 396
Hay, B., Henderson, C., Maltby, J., & Canales, J. J. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00211 · Cited by 24
Sleep Deficiency and Opioid Use Disorder
Langstengel, J., & Yaggi, H. K. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.05.001 · Cited by 26
A dimensional approach to functional movement disorders: Heresy or opportunity
Spagnolo, P. A., Garvey, M., & Hallett, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.005 · Cited by 23
Neural oscillatory dynamics of inhibitory control in young adult binge drinkers
Holcomb, L. A., Huang, S., Cruz, S. M., & Marinković, K. (2019) · Biological Psychology · doi:10.1016/j.biopsycho.2019.107732 · Cited by 25
Cofresí, R. U., Kohen, C. B., Motschman, C. A., Wiers, R. W. H. J., Piasecki, T. M., & Bartholow, B. D. (2021) · Addiction · doi:10.1111/add.15728 · Cited by 24
Alcohol use disorder criteria exhibit different comorbidity patterns
Watts, A. L., Watson, D., Heath, A. C., & Sher, K. J. (2023) · Addiction · doi:10.1111/add.16121 · Cited by 26
The Collaborative Study on the Genetics of Alcoholism: Overview
Arpana Agrawal, A., Brislin, S. J., Bucholz, K. K., Dick, D. M., Hart, R. P., Johnson, E. C., Meyers, J. L., Salvatore, J. E., Slesinger, P. A., Collaborators, C., et al. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12864 · Cited by 27
Kirsch, D. E., Grodin, E. N., Nieto, S. J., Kady, A., & Ray, L. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01877-4 · Cited by 21
Lima, D. R., Gonçalves, P. D., Ometto, M., Malbergier, A., do Amaral, R. A., dos Santos, B., Cavallet, M., Chaim-Avancini, T. M., Serpa, M. H., Ferreira, L. K., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.013 · Cited by 21
Rezapour, T., Barzegari, M., Sharifi, E., Malmir, N., Ghiasvand, H., Salehi, M., Noroozi, A., & Ekhtiari, H. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.809.3 · Cited by 21
An empirical study of affective and cognitive functions in Compulsive Sexual Behavior Disorder
Draps, M., Sescousse, G., Wilk, M., Obarska, K., Szumska, I., Żukrowska, W., Majkowska, A., Kowalewska, E., Szymanowska, J., Hamerska, U., et al. (2021) · Journal of Behavioral Addictions · doi:10.1556/2006.2021.00056 · Cited by 22
Eckert, D. J., & Yaggi, H. K. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-2014ci · Cited by 24
Brislin, S. J., Patrick, C. J., Flor, H., Nees, F., Heinrich, A., Drislane, L. E., Yancey, J. R., Banaschewski, T., Bokde, A. L. W., Bromberg, U., et al. (2018) · Assessment · doi:10.1177/1073191118759748 · Cited by 22
DeYoung, C. G., Blain, S. D., Latzman, R. D., Grazioplene, R. G., Haltigan, J. D., Kotov, R., Michelini, G., Venables, N. C., Docherty, A. R., Goghari, V. M., et al. (2024) · Journal of Psychopathology and Clinical Science · doi:10.1037/abn0000903 · Cited by 35
Mapping data‐driven individualized neurobehavioral phenotypes in heavy alcohol drinkers
DeMartini, K. S., Gueorguieva, R. V., Pearlson, G. D., Krishnan‐Sarin, S., Anticevic, A., Ji, L., Krystal, J. H., & O’Malley, S. S. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14580 · Cited by 21
Martins, J. S., Bartholow, B. D., Cooper, M. L., Irvin, K., & Piasecki, T. M. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14134 · Cited by 22
Chang, C., Chang, Y., Cheng, H., & Tzang, R. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa010 · Cited by 20
Vedelago, L., Wardell, J. D., Kempe, T., Patel, H., Amlung, M. T., MacKillop, J. M., & Keough, M. T. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107092 · Cited by 21
Nieto, S. J., & Ray, L. A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113876 · Cited by 19
Venables, N. C., Yancey, J. R., Kramer, M. D., Hicks, B. M., Krueger, R. F., Iacono, W. G., Joiner, T. E., & Patrick, C. J. (2017) · Psychological Medicine · doi:10.1017/s0033291717001830 · Cited by 22
Neuropsychological Constructs in Gaming Disorders: a Systematic Review
Legault, M. C. B., Liu, H. Z., & Balodis, I. M. (2021) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-021-00230-z · Cited by 18
Lechner, W. V., Gunn, R. L., Minto, A., Philip, N. S., Brown, R. A., Uebelacker, L. A., Price, L. H., & Abrantes, A. M. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1400569 · Cited by 19
Shi, Z., Langleben, D. D., O’Brien, C. P., Childress, A. R., & Wiers, C. E. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102806 · Cited by 18
Trapp, W., Heid, A., Röder, S., Wimmer, F., & Hajak, G. (2022) · Brain Sciences · doi:10.3390/brainsci12060683 · Cited by 23
Wang, T., Lu, R., Lee, S.-Y., Chang, Y.-H., Chen, S., Tsai, T.-Y., Tseng, H., Chen, P. S., Chen, K. C., Yang, Y. K., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac069 · Cited by 19
Verdejo‐García, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.07.015 · Cited by 18
Gunawan, T., Luk, J. W., Schwandt, M. L., Kwako, L. E., Vinson, T., Horneffer, Y. R., George, D. T., Koob, G. F., Ramchandani, V. A., Diazgranados, N., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02987-9 · Cited by 18
Self-citationSchmid, F., Benzerouk, F., Barrière, S., Henry, A., Limosin, F., Kaladjian, A., & Gierski, F. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14517 · Cited by 19
Lannoy, S., Adolf Pfefferbaum, A., Berre, A. L., Thompson, W. K., Brumback, T., Schulte, T., Pohl, K. M., Bellis, M. D. D., Nooner, K. B., Baker, F. C., et al. (2021) · Neuropsychology · doi:10.1037/neu0000771 · Cited by 17
Boness, C. L., Hasler, B. P., Sheehan, H., & Pedersen, S. L. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107348 · Cited by 17
Cognitive Alterations in Addictive Disorders: A Translational Approach
Gasparyan, A., Sanchez, D. M., Navarrete, F., Sión, A., Navarro, D., García‐Gutiérrez, M. S., Rubio, G., Barba, R. J., & Manzanares, J. (2023) · Biomedicines · doi:10.3390/biomedicines11071796 · Cited by 18
Luk, J. W., & Thompson, M. F. (2024) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2024.07.002 · Cited by 18
Long, E. C., Milcheva, S., Psederska, E., Vasilev, G. N., Bozgunov, K., Nedelchev, D., Gillespie, N. A., & Vassileva, J. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02296 · Cited by 17
Upadhyay, J., Verrico, C. D., Cay, M., Kodele, S., Yammine, L., Koob, G. F., & Schreiber, R. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00008-0 · Cited by 16
Self-citationA systematic review of treatment for impulsivity and compulsivity
Yamuza, B. A., Trenados, Y., Herruzo, C., Osuna, M. J. P., & Herruzo, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1430409 · Cited by 22
Linn, B. K., Zhao, J., Stasiewicz, P. R., LaBarre, C., Wilding, G. E., & Bradizza, C. M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109695 · Cited by 17
Kittaneh, A. A., Patel, S. V., Sidhu, N. K., Lechner, W. V., & Kenne, D. R. (2021) · Tobacco Use Insights · doi:10.1177/1179173x211004267 · Cited by 16
Spagnolo, P. A., Pérez, L. J. G., Terraneo, A., Gallimberti, L., & Bonci, A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14313 · Cited by 19
Carr, K. L., & Stewart, M. W. (2019) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2019.04.013 · Cited by 16
ICD ‐11 for Alcohol Use Disorders: Not a Convincing Answer to the Challenges
Rehm, J. T., Heilig, M. A., & Gual, A. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14182 · Cited by 17
Relationships Between Alexithymia and Psychopathy in Heroin Dependent Individuals
Psederska, E., Savov, S., Atanassov, N., & Vassileva, J. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02269 · Cited by 16
Moderators of Substance Use Disorder Treatment for Adolescents
Bachrach, R. L., & Chung, T. A. (2020) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2020.1790379 · Cited by 16
Connecting quantitatively derived personality–psychopathology models and neuroscience
Latzman, R. D., Krueger, R. F., DeYoung, C. G., & Michelini, G. (2021) · Personality Neuroscience · doi:10.1017/pen.2021.3 · Cited by 14
Ifland, J., & Brewerton, T. D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1584891 · Cited by 17
Yücel, M., Lee, R. S. C., & Fontenelle, L. F. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0243 · Cited by 15
Addiction biotypes: a paradigm shift for future treatment strategies?
Pettorruso, M., Lorenzo, G. D., Risio, L. D., Carlo, F. D., d’Andrea, G., & Martinotti, G. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02423-w · Cited by 14
A Model-Based Strategy for Interfacing Traits of the DSM-5 AMPD With Neurobiology
Bowyer, C. B., Joyner, K. J., Latzman, R. D., Venables, N. C., Foell, J., & Patrick, C. J. (2020) · Journal of Personality Disorders · doi:10.1521/pedi.2020.34.5.586 · Cited by 18
Guerrin, C. G. J., Tesselaar, D. R. M., Booij, J., Schellekens, A., & Homberg, J. R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106311 · Cited by 15
Neurobiology and the Treatment of Alcohol Use Disorder: A Review of the Evidence Base
Donato, S., & Ray, L. A. (2023) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s409943 · Cited by 17
Rezapour, T., Rafei, P., Baldacchino, A., Conrod, P., Dom, G., Fishbein, D. H., Kazemi, A., Hendriks, V. M., Newton, N. C., Riggs, N. R., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105578 · Cited by 15
White, A. M., Eglovitch, M., Parlier‐Ahmad, A. B., Dzierzewski, J. M., James, M. H., Bjork, J. M., Moeller, F. G., & Martin, C. E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304461 · Cited by 16
Datta, U., Martini, M., & Sun, W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4808-1 · Cited by 14
Self-Reported Symptoms of Cannabis Use Disorder (SRSCUD): Psychometric Testing and Validation
Richards, D. K., Schwebel, F. J., Sotelo, M., & Pearson, M. (2021) · Experimental and clinical psychopharmacology · doi:10.1037/pha0000455 · Cited by 12
Tzang, R., Chang, C., & Chang, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116648 · Cited by 15
Yen, J., Chou, W., Liao, H.-Y., & Ko, C. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00459-y · Cited by 14
Cates, H. M., Benca‐Bachman, C. E., de Guglielmo, G., Schoenrock, S. A., Shu, C., & Kallupi, M. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12577 · Cited by 14
A conceptual framework for the intersection of hyperalgesia and hyperkatifeia in alcohol addiction
Koob, G. F., & Vendruscolo, L. F. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.08.004 · Cited by 14
Self-citationPallanti, S., Marras, A. M., & Makris, N. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.634418 · Cited by 15
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Belnap, M. A., McManus, K. R., Grodin, E. N., & Ray, L. A. (2024) · Pharmaceutical Medicine · doi:10.1007/s40290-024-00526-x · Cited by 13
Lin, E. R.-H., Veenker, F., Manza, P., Yonga, M.-V., Abey, S. K., Wang, G., & Volkow, N. D. (2024) · Brain Sciences · doi:10.3390/brainsci14121285 · Cited by 15
Strong and weak cross-inheritance of substance use disorders in a nationally representative sample
Zhang, H., Grant, B. F., Hodgkinson, C. A., Ruan, W. J., Kerridge, B. T., Huang, B., Saha, T. D., Fan, A. Z., Wilson, V., Jung, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01370-0 · Cited by 16
Self-citationLandefeld, C. C., Hodgkinson, C. A., Spagnolo, P. A., Marietta, C. A., Shen, P., Sun, H., Zhou, Z., Lipska, B. K., & Goldman, D. A. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0120-z · Cited by 13
Self-citationWilcox, C. E., Clifford, J. M., Ling, J. M., Mayer, A. R., Bigelow, R., Bogenschutz, M. P., & Tonigan, J. S. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00126-3 · Cited by 13
Commentary: Perspectives on alcohol‐related gene and environment interplay in diverse populations
Scott, M. S. (2017) · American Journal on Addictions · doi:10.1111/ajad.12584 · Cited by 12
Miller, M. B., Freeman, L. K., Park, C. J., Hall, N. A., Deroche, C. B., Sahota, P. K., & McCrae, C. S. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14603 · Cited by 12
Translational models of addiction phenotypes to advance addiction pharmacotherapy
Ray, L. A., Nieto, S. J., & Grodin, E. N. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14929 · Cited by 14
Hetland, J., Hagen, E., Lundervold, A. J., & Erga, A. H. (2023) · European Addiction Research · doi:10.1159/000528921 · Cited by 12
Kohen, C. B., Cofresí, R. U., Piasecki, T. M., & Bartholow, B. D. (2024) · Addiction Biology · doi:10.1111/adb.13368 · Cited by 12
Pich, E. M., Tarnanas, I., Brigidi, P., & Collo, G. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100713 · Cited by 16
Genetically influenced externalizing and internalizing risk pathways as novel prevention targets.
Dick, D. M., Saunders, T. R., Balcke, E., Driver, M. N., Neale, Z. E., Vassileva, J., & Langberg, J. M. (2021) · Psychology of Addictive Behaviors · doi:10.1037/adb0000759 · Cited by 12
Maurage, P., Lannoy, S., Dormal, V., Blanco, M., & Trabut, J. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13873 · Cited by 14
Oberlin, B. G., Shen, Y. I., & Kareken, D. A. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00817-1 · Cited by 14
Kwon, M., Lee, S. H., & Ahn, W. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.12.003 · Cited by 14
Wilcox, C. E., Claus, E. D., Calhoun, V. D., Rachakonda, S., Littlewood, R. A., Mickey, J., Arenella, P. B., Goodreau, N., & Hutchison, K. E. (2017) · Addiction Biology · doi:10.1111/adb.12498 · Cited by 12
Ghitza, U. E. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00002 · Cited by 12
RNA biomarkers for alcohol use disorder
Ferguson, L. B., Mayfield, R. D., & Messing, R. O. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1032362 · Cited by 12
Gibson, B. C., Claus, E. D., Sanguinetti, J., Witkiewitz, K. A., & Clark, V. P. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104821 · Cited by 12
Alcohol use disorder conceptualizations and diagnoses reflect their sociopolitical context
Boness, C. L., Votaw, V. R., Francis, M. W., Watts, A. L., Sperry, S. H., Kleva, C. S., Nellis, L., McDowell, Y. E., Douaihy, A. B., Sher, K. J., et al. (2022) · Addiction Research & Theory · doi:10.1080/16066359.2022.2150935 · Cited by 11
Георгиевна, К. С., Андреевна, Б. А., Trusova, A. V., Podoliak, D. V., Валерьевна, Р. К., & Krupitsky, E. M. (2022) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2022-4-63-76 · Cited by 11
Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence
Psederska, E., & Vassileva, J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021236 · Cited by 13
Blum, K., Green, R. R., Smith, J., Llanos-Gomez, L., Baron, D. A., & Badgaiyan, R. D. (2020) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000245 · Cited by 11
Pharmacological cognitive enhancers
Peltier, M. R., & Sofuoglu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00023-x · Cited by 9
Modern pharmacotherapy guidance for treating alcohol use disorders
Soyka, M., & Rösner, S. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2445734 · Cited by 11
The Dynorphin/-Opioid Receptor System at the Interface of Hyperalgesia/Hyperkatifeia and Addiction
Marchette, R. C. N., Vendruscolo, L. F., & Koob, G. F. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00618-x · Cited by 17
Self-citationNeurocognitive Disorders in Substance Use Disorders
Ekhtiari, H., Zare-Bidoky, M., & Verdejo‐García, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_81 · Cited by 10
Akhurst, J., Lovell, M. E., Peacock, A., & Bruno, R. (2021) · Pain Medicine · doi:10.1093/pm/pnab005 · Cited by 10
Hetland, J., Lundervold, A. J., & Erga, A. H. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05600-x · Cited by 10
Joyner, K. J., Yancey, J. R., Venables, N. C., Burwell, S. J., Iacono, W. G., & Patrick, C. J. (2019) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2019.11.012 · Cited by 10
Dacosta‐Sánchez, D., González‐Ponce, B. M., Fernández‐Calderón, F., Tejada, A. J. R., Ordóñez-Carrasco, J. L., & Lozano, O. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108349 · Cited by 10
Characteristics Associated With High-Intensity Binge Drinking in Alcohol Use Disorder
Gowin, J. L., Sloan, M. E., Morris, J. K., Schwandt, M. L., Diazgranados, N., & Ramchandani, V. A. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.750395 · Cited by 10
Moniz-Lewis, D. I. K., Carlon, H. A., Hebden, H. M., Tuchman, F. R., Votaw, V. R., Stein, E., & Witkiewitz, K. A. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00487-2 · Cited by 12
Maurage, P., Rolland, B., Pitel, A., & D’Hondt, F. (2023) · Neuropsychology Review · doi:10.1007/s11065-023-09623-1 · Cited by 11
Atypical effective connectivity from the frontal cortex to striatum in alcohol use disorder
Song, H., Yang, P., Zhang, X., Tao, R., Zuo, L., Liu, W., Fu, J., Kong, Z., Tang, R., Wu, S., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03083-8 · Cited by 9
Miguel, A. C., Smith, C. L., Rodin, N. M., Johnson, R. K., McDonell, M. G., & McPherson, S. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100140 · Cited by 9
Votaw, V. R., Boness, C. L., Stein, E., Watts, A. L., Sher, K. J., & Witkiewitz, K. A. (2023) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000648 · Cited by 9
Rösner, S., & Soyka, M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00644-0 · Cited by 9
Bianchi, P., Gomes‐de‐Souza, L., Ferreira, W. C., Palombo, P., de Oliveira, P. E. C., Engi, S. A., Leão, R. M., Planeta, C. S., Crestani, C. C., & Cruz, F. C. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00371-6 · Cited by 11
Toward Refinement of Our Understanding of the Fundamental Nature of Addiction
DeVito, E. E., Carroll, K. M., & Sofuoglu, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.06.007 · Cited by 9
Negative affect and alcohol craving in trauma‐exposed young adult drinkers
Berenz, E. C., Zakeri, S. E., Demos, A. P., Paltell, K. C., Bing‐Canar, H., Kevorkian, S. S., & Ranney, R. M. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14641 · Cited by 9
Watts, A. L., Boness, C. L., Loeffelman, J. E., Steinley, D., & Sher, K. J. (2020) · doi:10.31234/osf.io/paxd4 · Cited by 9
Metadata
- Authors
- Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Kwako, Laura E.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 80
- Issue
- 3
- Pages
- 179-189
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC4870153
- OpenAlex
- W2207035985
- Semantic Scholar
- 621a35dbbd45d7e898e2999389a1fe6c88ac4688
- Cited by
- 395
- References
- 151
- Citations by year
- 2026: 48 · 2025: 32 · 2024: 46 · 2023: 38 · 2022: 43 · 2021: 47 · 2020: 38 · 2019: 46 · 2018: 24 · 2017: 27 · 2016: 6
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99‐AA999999)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- addiction, executive function, incentive salience, negative affectivity, addiction classification, Research Domain Criteria, neuroimaging, clinical heterogeneity, causes of addiction
- MeSH terms
- Emotions, Humans, Models, Psychological, Motivation, Neuropsychological Tests, Behavior, Addictive, Substance-Related Disorders, Executive Function, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
